Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
29.24 Down 0.27(0.91%) Jul 28, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 80,518   92,592   84,920   87,053  
Cost of Revenue15,688  18,536  17,372  17,092  
Gross Profit 64,830   74,056   67,548   69,961  
Operating Expenses
Research Development14,522  14,302  13,839  13,216  
Selling General and Administrative46,892  47,007  42,336  48,004  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 3,416   12,747   11,373   8,741  
Income from Continuing Operations
Total Other Income/Expenses Net172  167  162  166  
Earnings Before Interest And Taxes3,588  12,914  11,535  8,907  
Interest Expense92  286  544  749  
Income Before Tax3,496  12,628  10,991  8,158  
Income Tax Expense2,793  6,437  3,513  4,247  
Minority Interest -   -   -   -  
Net Income From Continuing Ops703  6,191  7,478  3,911  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 703   6,191   7,478   3,911  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 703   6,191   7,478   3,911  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.